Neurocrine Biosciences
NBIX
#1690
Rank
$12.90 B
Marketcap
$128.63
Share price
-1.13%
Change (1 day)
6.58%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024: $0.61 Billion USD

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are $2.68 Billion USD. In 2024 the company made an earning of $0.61 Billion USD, an increase over its 2023 earnings that were of $0.31 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024$0.61 B96.41%
2023$0.31 B41.13%
2022$0.22 B73.74%
2021$0.12 B-8.82%
2020$0.13 B77.78%
2019$78.46 M49.83%
2018$52.37 M-142.57%
2017-$0.13 Billion-14.73%
2016-$0.15 Billion53.15%
2015-$94.21 Million46.25%
2014-$64.42 Million29.66%
2013-$49.68 Million-3530.8%
2012$1.44 M-95.73%
2011$33.92 M
2009-$47.69 Million-45.38%
2008-$87.3 Million-58.87%
2007-$0.22 Billion87.3%
2006-$0.12 Billion351.97%
2005-$25.08 Million-52.09%
2004-$52.34 Million-10.98%
2003-$58.79 Million
2001-$43.89 Million
1999-$19.79 Million108.32%
1998-$9.5 Million
1996$2.9 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$11.85 B 1,932.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$1.66 B 184.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$22.50 B 3,758.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
$26.14 M-95.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-$41.77 Million-107.16%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
$50.55 M-91.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-$4.8 Million-100.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
$1.58 B 171.24%๐Ÿ‡ฌ๐Ÿ‡ง UK